Fundamentals of Screening for Mild Cognitive Impairment and/or Dementia
Audiologists play an important role as members of professional multi-disciplinary teams working to help people “age well.”
Tag: original
All
Latest
All
Latest
Empowering Patients with Personalized Compression
There is a strong case for personalization of compression for the individual hearing aid user, with research indicating large variation between individuals and situations in preferences and performance. Such personalization has, until now, been limited to complicated adjustments of gain and compression in the fitting software. In contrast, the new Widex MySound enables the user to personalize compression in a completely new way.
All
Latest
The Final…Final Word
Soon after leaving “The Hearing Journal,” I came to an agreement with Karl Strom to continue writing in my own style for “The Hearing Review.”
Noopl Announces Closing of Business
Hearing enhancement device developer and distributor Noopl has announced it is suspending the sales and marketing of its device. Launched at CES 2021 and honored with a CES 2022 Innovation Award, Noopl was a small $199 hearing accessory that clipped onto the bottom of an iPhone.
Read More
The Audiology Behind the Oticon Polaris Platform: Q&A with Virginia Ramachandran, PhD
Oticon Head of Audiology Virginia Ramachandran, PhD talks about the underlying hearing aid science and technology behind the recent additions in the Polaris platform.
Read More
Bose Exiting Hearing Aid Market; Pares Health Division
Bose is exiting the hearing aid market, according to an article in Tuesday’s “Boston Globe.” The Bose SoundControl hearing aid was the first FDA-cleared self-fitting hearing aid for mild-to-moderate hearing losses, and helped define this distinct class of devices. It’s possible the technology will be licensed or sold to another company.
Read More
Tribute: Sigfrid (Sig) Soli, PhD, Auditory and CI Researcher and Scientist
Sig Soli, PhD, an early researcher in cochlear implants, gifted instructor, and co-author of the widely used Hearing in Noise Test (HINT) in hearing aid fitting, died on April 11, 2022.
Read More
Three Specialized Lifestyle Models from Phonak: Audéo Fit, Phonak Slim, and Audéo Life
Phonak has added three specialized lifestyle models to its new series of Paradise-powered hearing aids, including Audéo Fit which provides the user with data about various health indicators, including heart rate, steps, and distances walked or run. The company also launched Phonak Slim, as well as the expansion of Phonak Audéo Life to all performance levels in the United States.
Read More
Hearing Aid Sales Continue to Reflect Pent-up Demand in Q1 2022
In the first quarter of 2022, hearing aid unit sales increased by 18.4% at the VA and by 5.7% for the private-practice and commercial market. In total, hearing aid sales increased by 7.8% compared to the same period last year when the market first started posting positive sales numbers following the Covid-19 pandemic.
Read More
M&As, the Blended Care Model, and Teleaudiology
What do the recent mergers and acquisitions (M&As) of hearing care dispensing networks mean for private practice audiologists and hearing aid specialists?
Read More
AAA 2022 Convention: Audiology on the Threshold of Change
The American Academy of Audiology (AAA) 2022 Convention in St Louis attracted about 2,200 people for four days of excellent learning opportunies, networking, and fun. Academy leaders are urging members to become more involved in this era of rapid change.
Read More
Evaluation of Apple AirPods Pro with Conversation Boost and Ambient Noise Reduction for People with Hearing Loss in Noisy Environments
How effective are the Conversation Boost (CB) and Ambient Noise Reduction (ANR) features in the extremely popular Apple Airpods Pro? Research at the National Acoustic Laboratories (NAL) show an improvement in SII-weighted SNR of around 7 dB for a talker located in front of the listener in a noisy environment for the CB-on and ANR-100% condition.
Read More
HR Insider: Eversound to Provide Teleaudiology Services to their 1,200 Senior Living Community Clients
Eversound, a company that provides assistive listening technology and social engagement applications to senior living communities, has announced its intention to provide teleaudiology services in these same centers and is actively seeking hearing care professionals to join their efforts.
Read More
iOS 15.4 Update May Necessitate Re-Pairing of Bluetooth Hearing Aids to Apps
After updating to iOS 15.4, some users of Bluetooth-enabled hearing aids—including many or most of the global brands—may experience problems pairing the devices to their respective apps. The problem appears to originate from Apple.
Read More
Using Simulation with CARL to Create Coaching Opportunities and Proficiency with REM
Simulation appears both sensitive to identifying training needs related to REM and other core competencies, such as cerumen management and earmold impressions, as well as capable of providing the necessary outlet for follow-up training. It also offers valuable opportunities for between-clinician comparison.
Read More
Hearing Care M&As Heat Up Again
Mergers and acquisitions came back strong in 2021 after the pandemic, and M&As have started strong in 2022.
Read More
R&D Tax Credits: A Potential Tax Tool for Hearing Care Practices Branching into New Areas
Created in 1981 to stimulate research and development (R&D) in the United States, the R&D tax credit is a dollar-for-dollar offset of federal income tax liability and, in certain circumstances, payroll tax liability. Although widely used by larger businesses, the tax credit was specifically modified to also apply for small and mid-sized companies.
Read More
Sudden Sensorineural Hearing Loss (SSNHL): A Status Report 2022
SSNHL remains a difficult problem to diagnose, manage, and resolve, say authors Douglas Beck, AuD, and Jed Grisel, MD. Although treatments for SSNHL include corticosteroids and hyperbaric oxygen therapy (preferably early after onset), there are no interventions with highly predictable successful outcomes. However, a variety of new therapeutic strategies are under investigation.
Read More